NCT02191046

Brief Summary

The purpose of this study is to the effect of squeezable bottle nasal irrigation device with syringe in children with sinusitis in symptom score and satisfaction to nasal irrigation

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 13, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 15, 2014

Completed
4 months until next milestone

Results Posted

Study results publicly available

November 4, 2014

Completed
Last Updated

November 4, 2014

Status Verified

October 1, 2014

Enrollment Period

1.2 years

First QC Date

July 13, 2014

Results QC Date

July 15, 2014

Last Update Submit

October 31, 2014

Conditions

Keywords

nasal irrigationsinusitischildrenbuffered hypertonic salinenasal irrigation device

Outcome Measures

Primary Outcomes (1)

  • the Effect of Squeezable Bottle and Syringe on Clinical Effectiveness in Sinusitis Children

    For 5S-score, we measured the the mean 5-s score of both group at 2 weeks compare to the mean 5-s score at baseline visit and compare 5S-score between group at 2 weeks. The S5- score is a scale assessing severity of sinusitis. It compose of the symptom scores for nasal obstruction, day and nighttime cough, headache and nasal discharge. All symptom were graded from 0(no symptom) to 3 (severe ).The score were summed to give the mean 5S-score.It range from 0 (best possible outcome) to 15(worst possible outcome). 7-point Likert scale for satisfaction score is scale from 1 (indicating unsatisfactory) to 7 (indicating excellent). For satisfaction, we reported the result in the term of 7 points Likert scale and compare these scale between group at 2 weeks after treatment

    compare 5S-score of both group at 2 week and at baseline visit .compare the mean 5S-score and satisfaction score between both group at 2 weeks after treatment

Secondary Outcomes (1)

  • the Contamination in Nasal Irrigation Devices

    at second week after treatment

Study Arms (2)

syringe 20 ml

ACTIVE COMPARATOR

nasal irrigation with syringe by using buffer hypertonic saline about 100-240 ml until no nasal discharge

Device: syringe 20 ml

squeezable bottle

EXPERIMENTAL

nasal irrigation with squeezable bottle by using buffer hypertonic saline about 100-240 ml until no nasal discharge

Device: squeezable bottle

Interventions

nasal irrigation twice daily for 2 weeks period

Also known as: EEZNIS
squeezable bottle

nasal irrigation twice daily for 2 weeks

syringe 20 ml

Eligibility Criteria

Age3 Years - 15 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • age 3-15 years
  • diagnose sinusitis by each of following criteria 2.1 persistent upper respiratory infection symptoms \> or = 10 days 2.2. severe upper respiratory infection symptom with greenish discharge per nose or periorbital swelling 2.3 double sickening of upper respiratory infection symptoms

You may not qualify if:

  • patient who has history of penicillin allergy
  • patient who has complication of sinusitis
  • patient with a history of nasal anatomical defects
  • patient who has immune deficiency or primary ciliary dyskinesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Araya Satdhabudha

Klongluang, Pratumthanee, Thailand

Location

MeSH Terms

Conditions

Sinusitis

Interventions

Syringes

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Results Point of Contact

Title
Dr.Araya Satdhabudha
Organization
Thammasat university

Study Officials

  • Araya Satdhabudha, MD

    Thammasat University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
clinical professor

Study Record Dates

First Submitted

July 13, 2014

First Posted

July 15, 2014

Study Start

March 1, 2013

Primary Completion

May 1, 2014

Study Completion

May 1, 2014

Last Updated

November 4, 2014

Results First Posted

November 4, 2014

Record last verified: 2014-10

Locations